-
1
-
-
40349084052
-
-
Velcade package insert. Toronto ON, Ortho-Biotech; 2005 Jan
-
Velcade package insert. Toronto (ON): Ortho-Biotech; 2005 Jan.
-
-
-
-
2
-
-
0028347713
-
Chemotherapy waste reduction through shelf-life extension
-
Walker SE, DeAngelis C, Iazzetta J, Gafni A. Chemotherapy waste reduction through shelf-life extension. Can J Hosp Pharm 1994;47(1):15-23.
-
(1994)
Can J Hosp Pharm
, vol.47
, Issue.1
, pp. 15-23
-
-
Walker, S.E.1
DeAngelis, C.2
Iazzetta, J.3
Gafni, A.4
-
3
-
-
0020793667
-
Avoiding common flaws in stability and compatibility studies of injectable drugs
-
Trissel LA. Avoiding common flaws in stability and compatibility studies of injectable drugs. Am J Hosp Pharm 1983;40(7):1159-1160.
-
(1983)
Am J Hosp Pharm
, vol.40
, Issue.7
, pp. 1159-1160
-
-
Trissel, L.A.1
-
4
-
-
0024041981
-
Stability studies: Five years later
-
Trissel LA, Flora KP. Stability studies: five years later. Am J Hosp Pharm 1988;45(7):1569-1571.
-
(1988)
Am J Hosp Pharm
, vol.45
, Issue.7
, pp. 1569-1571
-
-
Trissel, L.A.1
Flora, K.P.2
-
5
-
-
27744454592
-
Policy for publication of chemical stability study manuscripts
-
Policy for publication of chemical stability study manuscripts. Can J Hosp Pharm 1990;43(1):3-4.
-
(1990)
Can J Hosp Pharm
, vol.43
, Issue.1
, pp. 3-4
-
-
-
6
-
-
23944476075
-
Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial
-
André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, et al. Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial. Ann Pharmacother 2005;39(9):1462-1466.
-
(2005)
Ann Pharmacother
, vol.39
, Issue.9
, pp. 1462-1466
-
-
André, P.1
Cisternino, S.2
Chiadmi, F.3
Toledano, A.4
Schlatter, J.5
Fain, O.6
-
7
-
-
84988175795
-
Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies
-
Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. J Pharm Sci 1992;81(3):309-312.
-
(1992)
J Pharm Sci
, vol.81
, Issue.3
, pp. 309-312
-
-
Shah, V.P.1
Midha, K.K.2
Dighe, S.3
McGilveray, I.J.4
Skelly, J.P.5
Yacobi, A.6
-
8
-
-
0018076475
-
The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials
-
Frieman JA, Chalmers TC, Smith H, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978;299(13):690-694.
-
(1978)
N Engl J Med
, vol.299
, Issue.13
, pp. 690-694
-
-
Frieman, J.A.1
Chalmers, T.C.2
Smith, H.3
Kuebler, R.R.4
-
9
-
-
0022613476
-
Sample size calculations for clinical pharmacology studies
-
Stolley PD, Strom BL. Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther 1986;39(5):489-490.
-
(1986)
Clin Pharmacol Ther
, vol.39
, Issue.5
, pp. 489-490
-
-
Stolley, P.D.1
Strom, B.L.2
|